Page last updated: 2024-10-21

3-methylcholanthrene and Fetal Resorption

3-methylcholanthrene has been researched along with Fetal Resorption in 2 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Fetal Resorption: The disintegration and assimilation of the dead FETUS in the UTERUS at any stage after the completion of organogenesis which, in humans, is after the 9th week of GESTATION. It does not include embryo resorption (see EMBRYO LOSS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khlood, EB1
Miyoshi, H1
Iwata, H1
Kazusaka, A1
Kon, Y1
Hadid, AH1
Moustafe, EK1
Ghonim, MH1
Fujita, S1
Lambert, GH1
Nebert, DW1

Other Studies

2 other studies available for 3-methylcholanthrene and Fetal Resorption

ArticleYear
Effects of concurrent exposure to 3-methylcholanthrene and vitamin A on fetal development in rats.
    The Japanese journal of veterinary research, 1999, Volume: 47, Issue:1-2

    Topics: Abnormalities, Drug-Induced; Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Femal

1999
Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse.
    Teratology, 1977, Volume: 16, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Ary

1977